Paradigm Biopharmaceuticals Ltd.ASX: PAR

Preliminary Results from Phase 2 MPS I Study

Nov 23, 2021 at 2:58 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment